Business & Regulation

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

From academia in Milan to professional development in the UK, Valo Therapeutics CEO Marcella Origgi shares her journey.

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity

Trump continues to send shockwaves through the industry. We look at FDA disruption, tariffs, funding volatility, and more.

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.

Our latest news roundup reports on Novartis’ new acquisition, an NIH grant for an Alzheimer’s disease vaccine, and more

Attorney Generals claim: “This administration is not streamlining the federal government; they are sabotaging it.”

From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.

As mental health disorders escalate, pharmaceutical innovators can harness advanced tools to accelerate much-needed treatments.